{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18512984", "DateCompleted": {"Year": "2008", "Month": "09", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "05", "Day": "31"}], "Language": ["eng"], "ELocationID": ["10.1021/np070458f"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "71", "Issue": "6", "PubDate": {"Year": "2008", "Month": "Jun"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells.", "Pagination": {"StartPage": "1049", "EndPage": "1051", "MedlinePgn": "1049-51"}, "Abstract": {"AbstractText": ["Tenacissimoside A (1) and 11alpha-O-benzoyl-12beta- O-acetyltenacigenin B (2), two derivatives of tenacigenin B (3) from the plant Marsdenia tenacissima, reversed multidrug resistance in P-glycoprotein (Pgp)-overexpressing multidrug-resistant cancer cells. The sensitivity of HepG2/Dox cells to the antitumor drugs doxorubicin, vinblastine, puromycin, and paclitexel was increased by 18-, 10-, 11-, and 6-fold by 20 microg/mL (or 25 microM) of 1 and 16-, 53-, 16-, and 326-fold by 20 microg/mL (or 39 microM) of 2, respectively. A preliminary mechanistic study has suggested that 1 might modulate Pgp-mediated multidrug resistance through directly interacting with the Pgp substrate site."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Group of Pharmaceutical Sciences, Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou 510405, People's Republic of China. yingjiehu@163.net"}], "Identifier": [], "LastName": "Hu", "ForeName": "Ying-Jie", "Initials": "YJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shen", "ForeName": "Xiao-Ling", "Initials": "XL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lu", "ForeName": "Hong-Long", "Initials": "HL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Yu-Hu", "Initials": "YH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huang", "ForeName": "Xin-An", "Initials": "XA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fu", "ForeName": "Lin-Chun", "Initials": "LC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fong", "ForeName": "Wang-Fun", "Initials": "WF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "11alpha-O-benzoyl-12beta-O-acetyltenacigenin B"}, {"RegistryNumber": "0", "NameOfSubstance": "ATP Binding Cassette Transporter, Subfamily B, Member 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Multidrug Resistance-Associated Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Steroids"}, {"RegistryNumber": "0", "NameOfSubstance": "tenacigenin B"}, {"RegistryNumber": "0", "NameOfSubstance": "tenacissimoside A"}, {"RegistryNumber": "4A6ZS6Q2CL", "NameOfSubstance": "Puromycin"}, {"RegistryNumber": "5V9KLZ54CY", "NameOfSubstance": "Vinblastine"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "P88XT4IS4D", "NameOfSubstance": "Paclitaxel"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "ATP Binding Cassette Transporter, Subfamily B, Member 1"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Marsdenia"}, {"QualifierName": ["metabolism"], "DescriptorName": "Multidrug Resistance-Associated Proteins"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Paclitaxel"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Puromycin"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Steroids"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vinblastine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "6", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "9", "Day": "16", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "6", "Day": "3", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18512984", "10.1021/np070458f"]}}], "PubmedBookArticle": []}